Uğur Şahin

Uğur Şahin, born on September nineteenth, nineteen sixty-five, is a prominent German medical researcher and entrepreneur known for his groundbreaking contributions to cancer research and immunology. He is the co-founder and CEO of BioNTech, a pioneering biopharmaceutical company that developed the world’s first mRNA-based vaccine against COVID-19. In addition to his role at BioNTech, he serves as the chairman of the scientific management board of the Helmholtz Institute for Translational Oncology (HI-TRON), a cutting-edge research laboratory he co-founded in two thousand eighteen.

Originally from Turkey, Şahin's family relocated to Germany when he was just four years old. He grew up in Cologne, where he pursued his medical studies at the University of Cologne, culminating in a doctoral thesis focused on cancer immunotherapy. His early career was rooted in academia, where he worked as an oncohematology physician and conducted research at various university hospitals in Saarland and Zürich.

In two thousand, Şahin established a research group at the University of Mainz, eventually becoming a professor of experimental oncology in two thousand six. His entrepreneurial journey began in two thousand one when he co-founded two pharmaceutical companies with his partner and spouse, Özlem Türeci. The second venture, BioNTech, in collaboration with Pfizer Inc, played a crucial role in developing one of the major vaccines that combat the COVID-19 pandemic in two thousand twenty.

As a result of BioNTech's remarkable success, Şahin and Türeci achieved a significant milestone, becoming the first Germans of Turkish descent to be listed among Germany's one hundred wealthiest individuals. With over five hundred filed patent applications and patents to his name, Şahin continues to be a leading figure in the field of medical research and innovation.